RxDoctor Payments Data

Kristi Olson, MD

Family Medicine · Iron Mountain, MINPI 1265480297

Payments from drug & device makers

$1,444in general payments, 2019–2025

Across 75 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$592
  • Pfizer$198
  • Merck$145
  • Lilly USA, LLC$96
  • Novo Nordisk$72
  • Medtronic$41
  • plus $301 from 14 others

What the payments were for

  • Food & beverage$1,444100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,444 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$16,029
Medicare patients
52
Services billed
151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide79$91,415
EliquisApixaban110$79,372
TrulicityDulaglutide29$26,517
JardianceEmpagliflozin33$23,683
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$12,158
JanuviaSitagliptin Phosphate11$11,414
Tresiba Flextouch U-100Insulin Degludec17$10,094
ArexvyRsvpref3 Antigen/As01e/Pf30$8,937
Semglee (Yfgn) PenInsulin Glargine-Yfgn11$8,539
Emgality PenGalcanezumab-Gnlm12$8,210
SymbicortBudesonide/Formoterol Fumarate21$4,828
Atorvastatin Calcium489$4,694
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$4,282
Gabapentin163$2,442
Levothyroxine Sodium254$2,171

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$72$91,41579 claims
PfizerEliquis$198$79,372110 claims
Lilly USA, LLCTrulicity$96$26,51729 claims
GSKTrelegy Ellipta, Arexvy$24$21,09645 claims
MerckJanuvia$145$11,41411 claims
AstraZenecaSymbicort$11$4,82821 claims
AbbVieSynthroid$592$1,04730 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Iron Mountain

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →